ARTICLE | Financial News
Halozyme completes debt financing
January 21, 2013 8:00 AM UTC
Halozyme Therapeutics Inc. (NASDAQ:HALO), San Diego, Calif. Business: Endocrine/Metabolic, Cancer, Dermatology Date completed: 1/4/13 Type: Debt financing Raised: $30 million Investors: Oxford Finance...